Haemonetics (HAE) Tops Q3 EPS by 3c; Offers Guidance
Tweet
Share
E-mailGet Alerts HAE Hot Sheet
Price: $108.41 --0%
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
DOYU, TWIN, FLO, More
Financial Fact:
Research, development and engineering: 8.34M
Today's EPS Names:
DOYU, TWIN, FLO, More
Join SI Premium – FREE
Haemonetics (NYSE: HAE) reported Q3 EPS of $0.85, $0.03 better than the analyst estimate of $0.82. Revenue for the quarter came in at $305.3 million versus the consensus estimate of $299.08 million.
GUIDANCE:
Haemonetics sees FY2023 EPS of $2.90-$3.00, versus the consensus of $2.92.
For earnings history and earnings-related data on Haemonetics (HAE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- ATRenew Inc (RERE) Tops Q2 EPS by 8c ; Offers Guidance
- Analog Devices (ADI) Tops Q3 EPS by 11c, Beats on Revenue; Offers Q4 Guidance
- Webull Corp (BULL) Tops Q2 EPS by 1c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
